1 |
Zingarelli B, Sheehan M, Hake PW, et al (2003). Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta (12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol, 171, 6827-37.
DOI
|
2 |
Zoli W, Ulivi P, Tesei A. et al (2005). Addition of 5-fluorouracil to doxorubicin- paclitaxel sequence increases caspasedependent apoptosis in breast cancer cell lines. Breast Cancer Res, 7, 681-9.
DOI
|
3 |
Kim HJ, Kim JY, Meng Z, et al (2007). 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. Cancer Res, 67, 2595-602.
DOI
|
4 |
Lecomte J, Flament S, Salamone S, et al (2008). Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines. Breast Cancer Res Treat, 112, 437-51.
DOI
|
5 |
Kim JH, Song J, Park KW (2015). The multifaceted factor peroxisome proliferator- activated receptor () in metabolism, immunity, and cancer. Arch Pharm Res, 38, 302-12.
DOI
|
6 |
Kocanova S, Mazaheri M, Caze-Subra S, et al (2010). Ligands specify estrogen receptor alpha nuclear localization and degradation. BMC Cell Biol, 11, 98.
DOI
|
7 |
Landar A, Shiva S, Levonen AL, et al (2006). Induction of the permeability transition and cytochrome c release by 15-deoxy-Delta12,14-prostaglandin J2 in mitochondria. Biochem J, 394, 185-95.
DOI
|
8 |
Li H, Pauza CD (2009). Effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and rosiglitazone on human gammadelta2 T cells. PLoS One, 4, 7726.
DOI
|
9 |
McKeage K, Curran MP, Plosker GL (2004). Fulvestrant: a review of its use in hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Drugs, 64, 633-8.
DOI
|
10 |
Monteith GR, Mcandrew D, Faddy HM, et al (2007). Calcium and cancer: targeting transport. Nat Rev Cancer, 7, 519-30.
DOI
|
11 |
Pacher P, Hajnoczky G (2001). Propagation of the apoptotic signal by mitochondrial waves. EMBO J, 20, 4107-21.
DOI
|
12 |
Mughal A, Kumar D, Vikram A (2015). Effects of Thiazolidinediones on metabolism and cancer: Relative influence of and IGF-1 signaling. Eur J Pharmacol, 768, 217-25.
DOI
|
13 |
Napimoga MH, Demasib APD, Bossonarob JP et al (2013). Low doses of 15d-PGJ2 induce osteoblast activity in a PPAR-gamma independent manner. International Immunopharmacol, 16, 131-8.
DOI
|
14 |
Orrenius S, Zhivotovsky B, Nicotera P (2003). Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol, 4, 552-65.
DOI
|
15 |
Parrish AB, Freel CD and Kornbluth S (2013). Cellular Mechanisms Controlling Caspase Activation and Function Cold Spring Harb Perspect Biol, 5, 8672.
DOI
|
16 |
Popolo A, Piccinelli AL, Morello S, et al (2011). Cytotoxic activity of nemorosone in human MCF-7 breast cancer cells. Can J Physiol Pharmacol, 89, 50-7.
DOI
|
17 |
Qin C, Burghardt R, Smith R, et al (2003). Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells. Cancer Res, 63, 958-64.
|
18 |
Shin SW, Seo CY, Han H, et al (2009). 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin Cancer Res, 15, 5414-25.
DOI
|
19 |
Rao GK, Zhang W, Kaminski NE (2004). Cannabinoid receptormediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells. J Leukoc Biol, 75, 884-92.
DOI
|
20 |
Rizzuto R, Pinton P, Ferrari D, et al (2003). Calcium and apoptosis: facts and hypotheses. Oncogene, 22, 8619-27.
DOI
|
21 |
Yen CC, Hsiao CD, Chen WM, et al. (2014). Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. Oncotarget, 5, 716-25.
DOI
|
22 |
Twiddy D, Cohen GM, Macfarlane M, et al (2006). Caspase-7 is directly activated by the approximately 700-kDa apoptosome complex and is released as a stable XIAPcaspase-7 approximately 200-kDa complex. J Biol Chem, 281, 3876-88.
DOI
|
23 |
Wen J, Huang YC, Xiu HH, et al (2016). Altered expression of stromal interaction molecule (STIM)-calcium releaseactivated calcium channel protein (ORAI) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in cancer: will they become a new battlefield for oncotherapy? Chin J Cancer, 35, 32.
DOI
|
24 |
Yaacob NS, Nasir R, Norazmi MN (2013). Influence of 17betaestradiol on 15- deoxy-delta12,14 prostaglandin J2 -induced apoptosis in MCF-7 and MDA-MB-231 cells. Asian Pac J Cancer Prev, 14, 6761-7.
DOI
|
25 |
Cho WH, Choi CH, Park JY, et al (2006). 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells. Neurochem Res, 31, 1247-54.
DOI
|
26 |
Yu K, He Y, Yeung LW, et al (2008). DE-71-induced apoptosis involving intracellular calcium and the Bax-mitochondriacaspase protease pathway in human neuroblastoma cells in vitro. Toxicol Sci, 104, 341-51.
DOI
|
27 |
Chaffer CL, Thomas DM, Thompson EW, et al (2006). PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma. BMC Cancer, 6, 53.
DOI
|
28 |
Chen Y, Li Z, He Y, et al (2014). Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a 14 novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol, 275, 176-81.
DOI
|
29 |
Croasdell A, Duffney PF, Kim N, et al (2015). and the innate immune system mediate the resolution of inflammation. PPAR Res, 2015, 549691.
|
30 |
Ciucci A, Gianferretti P, Piva R, et al (2006). Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway. Mol Pharmacol, 70, 1812-21.
DOI
|
31 |
Decuypere J-P, Monaco G, Bultynck G, et al (2011). The IP3 receptor-mitochondria connection in apoptosis and autophagy. Biochimica et Biophysica Acta, 1813, 1003-13.
DOI
|
32 |
Fujita M, Tohji C, Honda Y, et al (2012). Cytotoxicity of 15-deoxy-Delta(12,14)- prostaglandin J(2) through PPARgamma-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma. Int J Med Sci, 9, 555-66.
DOI
|
33 |
Dejeana LM, Martinez-Caballeroa S, Manonb S, et al (2006). Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins. Biochimica et Biophysica Acta, 1762, 191-201.
DOI
|
34 |
Dionne S, Levy E, Levesque D, et al (2010). PPARgamma ligand 15-deoxy-delta 12,14-prostaglandin J2 sensitizes human colon carcinoma cells to TWEAK-induced apoptosis. Anticancer Res, 30, 157-66
|
35 |
Egger J, Fischer S, Bretscher P, et al (2015). Total synthesis of prostaglandin 15d- PGJ2 and investigation of its effect on the secretion of IL-6 and IL-12. Org. Lett, 17, 4340-3.
DOI
|
36 |
Jo DG, Jun JI, Chang JW, et al (2004). Calcium binding of ARC mediates regulation of caspase 8 and cell death. Mol Cell Biol, 24, 9763-70.
DOI
|
37 |
Kim EJ, Park KS, Chung SY, et al (2003). Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. J Pharmacol Exp Ther, 307, 505-17.
DOI
|